Market Cap 34.44M
Revenue (ttm) 48.87M
Net Income (ttm) -1.05M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2.15%
Debt to Equity Ratio 0.00
Volume 200
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 894,000.00
Stochastic %K 52%
Beta -0.08
Analysts Strong Buy
Price Target N/A

Company Profile

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides contract research services in the areas of AIDS, influenza, respiratory syncytial virus, Coronavirus, malaria, hepatitis, cancer, and other infectious diseases, as well as flavivirus infections, including zika and dengue. It also offers small and large animal models. In addition, the company provides cell-based assays, immunoassay, toxicology...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 240 404 7654
Address:
9620 Medical Center Drive, Suite 310, Rockville, United States
Latest News on BIOQ
No data available.